Detalhe da pesquisa
1.
Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors.
Bioorg Med Chem Lett
; 28(22): 3529-3533, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30316633
2.
Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant.
ACS Infect Dis
; 8(4): 768-777, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319198
3.
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections.
ACS Cent Sci
; 8(8): 1145-1158, 2022 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36032774
4.
Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections".
ACS Cent Sci
; 8(9): 1362, 2022 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36188352
5.
Chemical Screen for Vancomycin Antagonism Uncovers Probes of the Gram-Negative Outer Membrane.
ACS Chem Biol
; 16(5): 929-942, 2021 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974796